Moreover, DDR1 depletion with two different shRNAs strongly inhibited the invasive capacities of KRAS‐mutated HCT116 and BRAF‐mutated HT29 CRC cells in vitro (Fig 2A–C). Here, DDR1 is linked to colorectal carcinoma.